Michael Stucky is a professional with extensive experience in investment, coaching, and entrepreneurship. Currently, he serves as Chief Investment Officer and Venture Partner at deep-tech focused Serpentine Ventures, focusing on scouting and partnerships. Concurrently, Michael offers guidance and mentorship at ETH Zurich and Innosuisse, nurturing talent for nearly a decade. As Co-founder and Chairman of Auxivo AG, he plays a crucial role in steering the company’s growth. Moreover, Michael chairs the Board of Directors at FenX. He was also the Co-founder & Executive Director of Anjarium Biosciences, as well as the Co-founder and CFO of GlycoVaxyn AG, which was sold to GSK in February 2015.
"*" indicates required fields
